VEGFA and neoplasm: The production of antagonistic VEGF-A mutants, VEGF receptor inhibitors, antisense mRNA-expressing constructs, inhibitory soluble receptors and humanized monoclonal antibodies against human VEGF-A are some of the strategies that are being undertaken to treat VEGF-induced tumour angiogenesis.